Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nesiritide in Heart Failure Patients Undergoing CABG (NAPA-CS)
NCT00530361Phase 3Withdrawn
- Sponsor
- Scios Inc.
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of nesiritide in acute kidney injury (AKI), sponsored by Scios Inc.. Status: withdrawn.
02
Drugs
nesiritide
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT00530361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00530361.